Proveris Scientific provides spray characterization test consulting services to nasal and aerosol spray drug product developers and manufacturers. Proveris can leverage its in-depth knowledge, resources, and technical expertise to assist pharmaceutical laboratories with device delivery development and regulatory submissions for:
- New Drug Applications
- Investigational New Drug Applications
- Abbreviated New Drug Applications
- Bioequivalence and Drug Product Stability Studies
- Ongoing, Small Batch Testing
- QA/QC Evaluations
- Cost Justification Reports
Proveris’s working relationship with FDA may provide useful insight to streamline the submission process.
Proveris’s Quality by Design-based patented process, Proveris by Design™, provides pharmaceutical organizations with a customized testing protocol that, when used with Proveris consulting services, has saved spray and aerosol drug developers 12 to 18 months in development time. The combination has also saved millions of dollars in costs.